JNK Signalling Regulates Self-Renewal of Proliferative Urine-Derived Renal Progenitor Cells via Inhibition of Ferroptosis

Cells. 2023 Sep 2;12(17):2197. doi: 10.3390/cells12172197.

Abstract

With a global increase in chronic kidney disease patients, alternatives to dialysis and organ transplantation are needed. Stem cell-based therapies could be one possibility to treat chronic kidney disease. Here, we used multipotent urine-derived renal progenitor cells (UdRPCs) to study nephrogenesis. UdRPCs treated with the JNK inhibitor-AEG3482 displayed decreased proliferation and downregulated transcription of cell cycle-associated genes as well as the kidney progenitor markers-SIX2, SALL1 and VCAM1. In addition, levels of activated SMAD2/3, which is associated with the maintenance of self-renewal in UdRPCs, were decreased. JNK inhibition resulted in less efficient oxidative phosphorylation and more lipid peroxidation via ferroptosis, an iron-dependent non-apoptotic cell death pathway linked to various forms of kidney disease. Our study is the first to describe the importance of JNK signalling as a link between maintenance of self-renewal and protection against ferroptosis in SIX2-positive renal progenitor cells.

Keywords: JNK signalling; cell death; ferroptosis; mitochondrial metabolism; self-renewal; urine stem cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ferroptosis*
  • Humans
  • Kidney
  • MAP Kinase Signaling System*
  • Renal Dialysis
  • Renal Insufficiency, Chronic*
  • Stem Cells

Grants and funding

J.A. acknowledges the medical faculty of Heinrich Heine University for financial support. J.A., C.B. and A.S.R. acknowledge that this work is partly funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)—417677437/GRK2578.